Citations

Showing 10 of 108083 citations.

TET2 Down-Regulation Confers Bortezomib Resistance in Multiple Myeloma
Liu, Xiaobo , Yang, Ting , Kumar, Shaji , Jin, Fengyan, Dai, Yun , Jin, Fengyan

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4185-4186

10.1182/blood-2022-168239 Get It

Clinical and Molecular Characteristics of ETV6 Mutated Myeloid Malignancies
Chekkaf, Ismahene, He, Rong , Viswanatha, David S., Mangaonkar, Abhishek A. , Begna, Kebede, Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Gurney, Mark E. , Greipp, Patricia T. , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6912-6914

10.1182/blood-2022-170641 Get It

CPX-351 for Blast-Phase Myeloproliferative Neoplasm (MPN-BP): Mayo Clinic Experience in 10 Consecutive Patients
Ilyas, Rimal, Patnaik, Mrinal M. , Mangaonkar, Abhishek A. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Badar, Talha , Alkhateeb, Hassan B.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9704-9705

10.1182/blood-2022-160222 Get It

Gastrointestinal Manifestation of Langerhans Cell Histiocytosis
Zanwar, Saurabh , Medina, Aldo Acosta, Ruan, Gordon , Abeykoon, Jithma P. , Yao, Yuan , Young, Jason R. , Rech, Karen L. , Ravindran, Aishwarya , Go, Ronald S.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12259-12260

10.1182/blood-2022-165511 Get It

Advances in Cardiac Electrophysiology
Piccini, Jonathan P. , Russo, Andrea M. , Sharma, Parikshit S. , Kron, Jordana , Tzou, Wendy S. , Sauer, William H. , Park, David , Birgersdotter‐Green, Ulrika , Frankel, David S. , Healey, Jeff S. , Linz, Dominik , Wißner, Erik , Zeitler, Emily P. , Wang, Paul J. , Tzou, Wendy , Park, David S , Hummel, John , Koruth, Jacob , Linz, Dominik , Mittal, Suneet , Nair, Devi G , Nattel, Stanley , Noseworthy, Peter A , Steinberg, Benjamin A , Trayanova, Natalia A , Wan, Elaine Y , Wissner, Erik , Zeitler, Emily P , Wang, Paul J , Healey, Jeffrey S , Hummel, John D. , Noseworthy, Peter A. , Steinberg, Benjamin A. , Trayanova, Natalia A. , Wan, Elaine Y.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | November 28, 2022 | Volume: 15 | Issue: 12 | Pages: No page available

10.1161/circep.121.009911 | PMID 36441565 Get It

Despite the global COVID-19 pandemic, during the past 2 years, there have been numerous advances in our understanding of arrhythmia mechanisms and diagnosis and in new therapies. We increased our understanding of risk factors and mechanisms of atrial arrhythmias, the prediction of atrial arrhythmias, response to treatment, and outcomes using machine learning and artificial intelligence. There have been new technologies and techniques for atrial fibrillation ablation, including pulsed field ablation. There have been new randomized trials in atrial fibrillation ablation, giving insight about rhythm control, and long-term outcomes. There have been advances in our understanding of treatment of inherited disorders such as catecholaminergic polymorphic ventricular tachycardia. We have gained new insights into the recurrence of ventricular arrhythmias in the setting of various conditions such as myocarditis and inherited cardiomyopathic disorders. Novel computational approaches may help predict occurrence of ventricular arrhythmias and localize arrhythmias to guide ablation. There are further advances in our understanding of noninvasive radiotherapy. We have increased our understanding of the role of His bundle pacing and left bundle branch area pacing to maintain synchronous ventricular activation. There have also been significant advances in the defibrillators, cardiac resynchronization therapy, remote monitoring, and infection prevention. There have been advances in our understanding of the pathways and mechanisms involved in atrial and ventricular arrhythmogenesis.
Autoimmune Encephalitis Misdiagnosis in Adults
Geschwind, Michael D. , López‐Chiriboga, A. Sebastian , Blackburn, Kyle , Turaga, Sanchit, Binks, Sophie , Day, Gregory S. , Rodenbeck, Stefanie, Clardy, Stacey , Solomon, Andrew , Pittock, Sean J. , Dubey, Divyanshu , Ζεκερίδου, Αναστασία , Toledano, Michel , Turner, Lindsey E., Vernino, Steven , Irani, Sarosh R. , Pittock, S J , Irani, Sarosh R , Clardy, Stacey L , Day, Gregory S , Dubey, Divyanshu , Binks, Sophie N M , Vernino, Steven , Flanagan, Eoin P. , Zitser, Jennifer , Gelfand, Jeffrey M. , Dunham, Steven , McKeon, Andrew

Mayo Clinic

JAMA Neurology | November 28, 2022 | Volume: 80 | Issue: 1 | Pages: 30

10.1001/jamaneurol.2022.4251 | PMID 36441519 Get It

ImportanceAutoimmune encephalitis misdiagnosis can lead to harm.ObjectiveTo determine the diseases misdiagnosed as autoimmune encephalitis and potential reasons for misdiagnosis.Design, Setting, and ParticipantsThis retrospective multicenter study took place from January 1, 2014, to December 31, 2020, at autoimmune encephalitis subspecialty outpatient clinics including Mayo Clinic (n = 44), University of Oxford (n = 18), University of Texas Southwestern (n = 18), University of California, San Francisco (n = 17), Washington University in St Louis (n = 6), and University of Utah (n = 4). Inclusion criteria were adults (age ≥18 years) with a prior autoimmune encephalitis diagnosis at a participating center or other medical facility and a subsequent alternative diagnosis at a participating center. A total of 393 patients were referred with an autoimmune encephalitis diagnosis, and of those, 286 patients with true autoimmune encephalitis were excluded.Main Outcomes and MeasuresData were collected on clinical features, investigations, fulfillment of autoimmune encephalitis criteria, alternative diagnoses, potential contributors to misdiagnosis, and immunotherapy adverse reactions.ResultsA total of 107 patients were misdiagnosed with autoimmune encephalitis, and 77 (72%) did not fulfill diagnostic criteria for autoimmune encephalitis. The median (IQR) age was 48 (35.5-60.5) years and 65 (61%) were female. Correct diagnoses included functional neurologic disorder (27 [25%]), neurodegenerative disease (22 [20.5%]), primary psychiatric disease (19 [18%]), cognitive deficits from comorbidities (11 [10%]), cerebral neoplasm (10 [9.5%]), and other (18 [17%]). Onset was acute/subacute in 56 (52%) or insidious (>3 months) in 51 (48%). Magnetic resonance imaging of the brain was suggestive of encephalitis in 19 of 104 patients (18%) and cerebrospinal fluid (CSF) pleocytosis occurred in 16 of 84 patients (19%). Thyroid peroxidase antibodies were elevated in 24 of 62 patients (39%). Positive neural autoantibodies were more frequent in serum than CSF (48 of 105 [46%] vs 7 of 91 [8%]) and included 1 or more of GAD65 (n = 14), voltage-gated potassium channel complex (LGI1 and CASPR2 negative) (n = 10), N-methyl-d-aspartate receptor by cell-based assay only (n = 10; 6 negative in CSF), and other (n = 18). Adverse reactions from immunotherapies occurred in 17 of 84 patients (20%). Potential contributors to misdiagnosis included overinterpretation of positive serum antibodies (53 [50%]), misinterpretation of functional/psychiatric, or nonspecific cognitive dysfunction as encephalopathy (41 [38%]).Conclusions and RelevanceWhen evaluating for autoimmune encephalitis, a broad differential diagnosis should be considered and misdiagnosis occurs in many settings including at specialized centers. In this study, red flags suggesting alternative diagnoses included an insidious onset, positive nonspecific serum antibody, and failure to fulfill autoimmune encephalitis diagnostic criteria. Autoimmune encephalitis misdiagnosis leads to morbidity from unnecessary immunotherapies and delayed treatment of the correct diagnosis.
Simulations of shear wave propagation in tissue based on kidney transplant histology
Sanger, Nicholas M., Vasconcelos, Luiz, Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 28, 2022 | Volume: 152 | Issue: 4_Supplement | Pages: A47-A47

10.1121/10.0015492 Get It

End-stage kidney disease is the result of progressive declines in function and frequently requires a transplant. Maintaining kidney transplant health with regularly scheduled function tests or biopsies is necessary to adjust treatments. Ultrasound shear wave elastography (SWE) could provide an inexpensive, noninvasive modality to monitor allograft health. In this project, we built models of the kidney cortex from segmented kidney transplant histology images. We assigned viscoelastic properties, based on a Kelvin-Voigt model, to the major constituents, glomeruli, interstitia, tubules, and fluid and simulated the wave propagation through tissue with no disease, inflammation, interstitial fibrosis, and tubular atrophy. The resulting in silico wave motion in the time- and frequency-domains was characterized to compare the in silico and in vivo mechanical properties. We also attempted modeling the effects of perfusion by modifying the constituents’ viscoelastic properties. We found the most differentiation for shear elasticity, shear viscosity, and phase velocity dispersion in the inflammation patients. When accounting for perfusion we observed increases in shear wave group velocity, shear viscosity, and dispersion, bringing the results from in silico models in closer agreement with in vivo results. These results are encouraging and demonstrate first steps of simulating the shear wave propagation based on histological models.
Nonlinear least-squares estimation of shear elasticity and shear viscosity in viscoelastic media
Bannon, Nicholas A., McGough, Robert J., Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | November 28, 2022 | Volume: 152 | Issue: 4_Supplement | Pages: A46-A46

10.1121/10.0015491 Get It

Rapid simulations of three-dimensional (3D) shear wave propagation in viscoelastic media with a Kelvin-Voigt model are enabled by Green’s functions accelerated with graphics processing unit parallelization and high-performance computing resources. Cross-correlation analysis of the wave motion yields an estimate of shear elasticity, where the errors in the estimated values increase with rising shear viscosity. To reduce errors in the shear elasticity estimates, a nonlinear least-squares routine that accounts for the effects of propagation, attenuation, and dispersion is applied to 3D simulated shear wave data in viscoelastic media. The nonlinear least-squares approach also yields an estimate of the shear viscosity when applied to simulated particle velocity waveforms. Post-processing, cross-correlation analysis, and the nonlinear least-squares routine are evaluated on a desktop computer using MATLAB. Estimation of viscoelastic parameters is performed at the focal depth for several combinations of shear elasticity and shear viscosity. The errors in the estimated shear elasticities obtained from the nonlinear least-squares routine and cross-correlation are determined as a function of the input shear elasticity and shear viscosity values. The estimates provided by the nonlinear least-squares routine for shear elasticity and shear viscosity are shown to approach the simulation input values for each combination of viscoelastic parameters.
Myeloid Sarcoma in Myelodysplastic Syndrome : Review
Aldapt, Mahmood B, Abuasab, Tareq , Abbas, Feryal, Ahmed, Ashraf, Saeed, Sara , Shwaylia, Hawraa , Abdulla, Mohammad Abdul-Jaber, Soliman, Dina Sameh , Haddad, Fadi G. , Mosalem, Osama , Mohamed, Shehab

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12333-12334

10.1182/blood-2022-163324 Get It

Health-Related Quality of Life (HRQoL) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristin
Friedberg, Jonathan W. , Thompson, Carrie A. , Zhang, Huilai , Thiéblemont, Catherine , Hu, Bei , Fonseca, Gustavo , Kim, Won-Seog, Campinha‐Bacote, Avrita, Yan, Mark, Hirata, Jamie , Sugidono, Matthew , Lee, Calvin , Sharman, Jeff P. , Trněný, Marek , Morschhauser, Franck , Salles, Gilles , Reagan, Patrick Michael , Hertzberg, Mark , Smolewski, Piotr , Martelli, Maurizio , Mehta, Amitkumar

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6623-6626

10.1182/blood-2022-157761 Get It